Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""aspirin"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 54679
Tytuł:
Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity.
Autorzy:
Perić A; Department of Otorhinolaryngology, Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia.
Gaćeša D; Department of Otorhinolaryngology, ENT Hospital 'Dr. Žutić', Belgrade, Serbia.
Cvetković G; Department of Pulmonology, Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia.
Vojvodić D; Division of Clinical and Experimental Immunology, Faculty of Medicine of the Military Medical Academy, Institute for Medical Research, Belgrade, Serbia.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Feb; Vol. 11 (2), pp. e791.
Typ publikacji:
Journal Article
MeSH Terms:
Rhinitis*/metabolism
Nasal Polyps*
Sinusitis*/metabolism
Asthma, Aspirin-Induced*/metabolism
Humans ; Tryptases ; Inflammation Mediators/metabolism ; Cross-Sectional Studies ; Substance P ; Aspirin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.
Autorzy:
Tchekmedyian R; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Lundberg M; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Buchheit KM; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Maurer R; Center for Clinical Investigation, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Gakpo D; Case Western Reserve University School of Medicine, Cleveland, USA.
Mullur J; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Bensko JC; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Laidlaw TM; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Dec; Vol. 52 (12), pp. 1414-1421. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Sinusitis*/epidemiology
Asthma, Aspirin-Induced*/epidemiology
Humans ; Female ; Quality of Life ; Anosmia ; Mental Health ; Aspirin/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Aspirin Caused Intestinal Damage through FXR and ET-1 Signaling Pathways.
Autorzy:
Lin Q; Laboratory of Hepatointestinal Diseases and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.; Department of Gastroenterology & Hepatology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhang B; Laboratory of Hepatointestinal Diseases and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.; Department of Gastroenterology & Hepatology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
Dai M; Department of Gastroenterology & Hepatology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
Cheng Y; Laboratory of Hepatointestinal Diseases and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.; Department of Gastroenterology & Hepatology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
Li F; Laboratory of Hepatointestinal Diseases and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.; Department of Gastroenterology & Hepatology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.; State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 18; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Aspirin*/adverse effects
Receptors, Cytoplasmic and Nuclear*/genetics
Animals ; Mice ; Intestines ; Bile Acids and Salts/pharmacology ; Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Signal Transduction ; Mice, Knockout
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multi-Omics Approaches for Liver Reveal the Thromboprophylaxis Mechanism of Aspirin Eugenol Ester in Rat Thrombosis Model.
Autorzy:
Tao Q; Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China.
Ma N; College of Veterinary Medicine, Hebei Agricultural University, Baoding 071001, China.
Fan L; Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China.
Ge W; Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China.
Zhang Z; Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China.
Liu X; Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China.
Li J; Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China.
Yang Y; Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou 730050, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 10; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
Venous Thromboembolism*/drug therapy
Thrombosis*/drug therapy
Thrombosis*/prevention & control
Thrombosis*/metabolism
Eugenol/*analogs & derivatives
Aspirin/*analogs & derivatives
Rats ; Animals ; Eugenol/pharmacology ; Eugenol/therapeutic use ; Eugenol/metabolism ; Anticoagulants/pharmacology ; Multiomics ; Aspirin/therapeutic use ; Liver/metabolism ; Fibrinogen/metabolism ; Orosomucoid/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization.
Autorzy:
Esmaeilzadeh H; Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran AND Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. esmailzadeh_.
Zare M; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .
Alyasin S; Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran AND Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. .
Nabavizadeh H; Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran AND Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. .
Mortazavi N; Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. mortazavi_.
Kanannejad Z; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. .
Pokaż więcej
Źródło:
Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2022 Oct 26; Vol. 21 (5), pp. 512-523. Date of Electronic Publication: 2022 Oct 26.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Asthma, Aspirin-Induced*/therapy
Sinusitis*
Nasal Polyps*/therapy
Nasal Polyps*/complications
Asthma*/drug therapy
Humans ; Desensitization, Immunologic ; Aspirin/adverse effects ; Chronic Disease
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Aspin: neurosurgical aspirin intervention prognostic study - perioperative continuation versus discontinuation of aspirin in lumbar spinal surgery, a randomized controlled, noninferiority trial.
Autorzy:
Zian A; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands. .; Department of Neurosurgery, Leiden University Medical center (LUMC), Leiden, The Netherlands. .; Department of Neurosurgery, Haga Teaching Hospital, The Hague, The Netherlands. .
Overdevest GM; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.; Department of Neurosurgery, Haga Teaching Hospital, The Hague, The Netherlands.
Schutte PJ; Department of Neurosurgery, Leiden University Medical center (LUMC), Leiden, The Netherlands.
Klok FA; Department of Vascular Internal Medicine, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
Steyerberg EW; Department of Clinical Biostatistics and Medical Decision Making, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
Moojen WA; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.; Department of Neurosurgery, Leiden University Medical center (LUMC), Leiden, The Netherlands.; Department of Neurosurgery, Haga Teaching Hospital, The Hague, The Netherlands.
van der Gaag NA; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.; Department of Neurosurgery, Leiden University Medical center (LUMC), Leiden, The Netherlands.; Department of Neurosurgery, Haga Teaching Hospital, The Hague, The Netherlands.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Feb 29; Vol. 25 (1), pp. 156. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Aspirin*/adverse effects
Thrombosis*
Humans ; Anticoagulants/therapeutic use ; Blood Loss, Surgical/prevention & control ; Neurosurgical Procedures ; Platelet Aggregation Inhibitors/adverse effects ; Prognosis ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Steroid affected cytokines in aspirin-exacerbated respiratory disease.
Autorzy:
Tan LH; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Lin C; Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA.
Ungerer H; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Kumar A; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Qatanani A; Drexel School of Medicine, Philadelphia, Pennsylvania, USA.
Adappa ND; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Palmer JN; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Bosso JV; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Reed D; Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA.
Cohen NA; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA.; Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
Kohanski MA; Department of Otorhinolaryngology-Head and Neck Surgery, Division of Rhinology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2022 Oct; Vol. 12 (10), pp. 1232-1241. Date of Electronic Publication: 2022 Jan 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Asthma, Aspirin-Induced*/drug therapy
Nasal Polyps*/drug therapy
Sinusitis*/chemically induced
Aspirin/adverse effects ; Cytokines ; Granulocyte-Macrophage Colony-Stimulating Factor ; Humans ; Interleukin-10 ; Interleukin-13 ; Interleukin-17 ; Interleukin-33 ; Interleukin-4 ; Interleukin-5 ; Interleukin-6 ; Lipids ; Prednisone/therapeutic use ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Raman spectra simulation of antiplatelet drug-platelet interaction using DFT.
Autorzy:
Kundalevich A; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia. .
Kapitunova A; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia.
Berezin K; Institute of Physics, Saratov State University, Saratov, 410012, Russia.
Zyubin A; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia.
Moiseeva E; Immanuel Kant Baltic Federal University, Kaliningrad, 236016, Russia.
Rafalskiy V; Immanuel Kant Baltic Federal University, Kaliningrad, 236016, Russia.
Samusev I; Immanuel Kant Baltic Federal University, REC 'Fundamental and Applied Photonics', Nanophotonics, Kaliningrad, 236016, Russia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1445. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Platelet Aggregation Inhibitors*/pharmacology
Platelet Aggregation Inhibitors*/metabolism
Aspirin*/pharmacology
Aspirin*/metabolism
Molecular Docking Simulation ; Blood Platelets/metabolism ; Clopidogrel
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial).
Autorzy:
Zapata-Arriaza E; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain. .; Interventional Neuroradiology Department, Virgen del Rocío University Hospital, Neurovascular Research Laboratory, Institute of Biomedicine of Seville (IBIS), Av Manuel Siurot sn, Seville, 41013, Spain. .
Medina-Rodríguez M; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen del Rocío University Hospital, Sevilla, Spain.
Moniche Álvarez F; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen del Rocío University Hospital, Sevilla, Spain.
de Albóniga-Chindurza A; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen del Rocío University Hospital, Sevilla, Spain.
Aguilar-Pérez M; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Interventional Neuroradiology Department, Virgen del Rocío University Hospital, Neurovascular Research Laboratory, Institute of Biomedicine of Seville (IBIS), Av Manuel Siurot sn, Seville, 41013, Spain.
Ainz-Gómez L; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen del Rocío University Hospital, Sevilla, Spain.
Baena-Palomino P; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen del Rocío University Hospital, Sevilla, Spain.
Zamora A; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.
Pardo-Galiana B; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen del Rocío University Hospital, Sevilla, Spain.
Delgado-Acosta F; Interventional Neuroradiology Department, Reina Sofía University Hospital, Córdoba, Spain.
Valverde Moyano R; Neurology Department, Reina Sofía University Hospital, Córdoba, Spain.
Jiménez-Gómez E; Interventional Neuroradiology Department, Reina Sofía University Hospital, Córdoba, Spain.
Bravo Rey I; Interventional Neuroradiology Department, Reina Sofía University Hospital, Córdoba, Spain.
Oteros Fernández R; Interventional Neuroradiology Department, Reina Sofía University Hospital, Córdoba, Spain.
Escudero-Martínez I; Neurology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
Vielba-Gomez I; Interventional Neuroradiology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
Morales Caba L; Interventional Neuroradiology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
Díaz Pérez J; Interventional Neuroradiology Department, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain.
García Molina E; Neurology Department, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain.
Mosteiro S; Interventional Neuroradiology Department, A Coruña University Hospital Complex, Coruña, Spain.
Castellanos Rodrigo MDM; Neurology Department, A Coruña University Hospital Complex, A Coruña, Spain.
Amaya Pascasio L; Neurology Department, Torrecardenas University Hospital, Almería, Spain.
Hidalgo C; Interventional Neuroradiology Department, Torrecardenas University Hospital, Almería, Spain.
Freijo Guerrero MDM; Neurology Department, Cruces University Hospital, Vizcaya, Spain.
González Díaz E; Interventional Neuroradiology Department, Cruces University Hospital, Vizcaya, Spain.
Ramírez Moreno JM; Neurology Department, Badajoz University Hospital, Badajoz, Spain.
Fernández Prudencio L; Interventional Neuroradiology, Badajoz University Hospital, Badajoz, Spain.
Terceño Izaga M; Department of Neurology, Doctor Josep Trueta Hospital, Girona, Spain.; Interventional Neuroradiology Unit, Doctor Josep Trueta Hospital, Girona, Spain.
Bashir Viturro S; Department of Neurology, Doctor Josep Trueta Hospital, Girona, Spain.; Interventional Neuroradiology Unit, Doctor Josep Trueta Hospital, Girona, Spain.
Gamero-García MÁ; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen Macarena University Hospital, Seville, Spain.
Jiménez Jorge S; Clinical Research and Clinical Trials Unit (CTU), Virgen del Rocío Hospital, Seville, Spain.
Rosso Fernández C; Clinical Research and Clinical Trials Unit (CTU), Virgen del Rocío Hospital, Seville, Spain.
Montaner J; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Neurology Department, Virgen Macarena University Hospital, Seville, Spain.
González García A; Stroke Unit, Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.; Interventional Neuroradiology Department, Virgen del Rocío University Hospital, Neurovascular Research Laboratory, Institute of Biomedicine of Seville (IBIS), Av Manuel Siurot sn, Seville, 41013, Spain.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Jan 09; Vol. 25 (1), pp. 35. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Aspirin*/adverse effects
Aspirin*/therapeutic use
Ischemic Stroke*
Thrombosis*
Tirofiban*/adverse effects
Tirofiban*/therapeutic use
Humans ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Aggregation Inhibitors/therapeutic use ; Prospective Studies ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts.
Autorzy:
Zhao J; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.
Duan R; Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
Sun J; Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
Chow RP; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.; Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
Lyons TJ; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.; Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.; Diabetes Free South Carolina, BlueCross BlueShield of South Carolina, Columbia, SC 29229, USA.
Yu JY; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, UK.; Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Jan 06; Vol. 13 (2). Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Aspirin*/pharmacology
Pre-Eclampsia*/drug therapy
Trophoblasts*/drug effects
Trophoblasts*/metabolism
Vascular Endothelial Growth Factor Receptor-1*/drug effects
Female ; Humans ; Pregnancy ; Hypoxia ; Placenta ; Receptor Protein-Tyrosine Kinases ; RNA, Messenger/genetics ; Salicylic Acid/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of aspirin desensitization outcomes between men and women with AERD.
Autorzy:
Tripathi SH; Division of Rhinology, Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Kumar A; Division of Rhinology, Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Kohanski MA; Division of Rhinology, Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Kennedy DW; Division of Rhinology, Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Palmer JN; Division of Rhinology, Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Adappa ND; Division of Rhinology, Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Bosso JV; Division of Rhinology, Department of Otorhinolaryngology, Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło:
International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2022 Jun; Vol. 12 (6), pp. 872-875. Date of Electronic Publication: 2022 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma, Aspirin-Induced*/therapy
Nasal Polyps*
Rhinitis*
Aspirin/adverse effects ; Chronic Disease ; Desensitization, Immunologic ; Female ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Theoretical basis validation and oxidative stress markers for cancer prevention clinical trials of aspirin.
Autorzy:
Hamoya T; Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Tomono S; Department of Microbiology and Immunology, Aichi Medical University, Nagakute, Aichi, 480-1195, Japan.
Miyamoto S; Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Fujii G; Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Wakabayashi K; Graduate Division of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka, 422-8526, Japan.
Mutoh M; Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan. .; Epidemiology and Prevention Division, Center for Public Health Sciences, National Cancer Center, Tokyo, 104-0045, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 11; Vol. 13 (1), pp. 21883. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Aspirin*/pharmacology
Aspirin*/therapeutic use
Adenomatous Polyposis Coli*/drug therapy
Adenomatous Polyposis Coli*/prevention & control
Adenomatous Polyposis Coli*/pathology
Humans ; Mice ; Animals ; Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Inflammation/drug therapy ; Oxidative Stress
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Unveiling the potential effects of acetylsalicylic acid: insights into regeneration in endometrial stem cells.
Autorzy:
Park SR; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea.; Department of Molecular Medicine, School of Medicine, Gachon University, Incheon, 406-840, Republic of Korea.
Kim SR; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea.; Department of Molecular Medicine, School of Medicine, Gachon University, Incheon, 406-840, Republic of Korea.
Min EK; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, 21999, Republic of Korea.; Department of Molecular Medicine, School of Medicine, Gachon University, Incheon, 406-840, Republic of Korea.
Oh BC; Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, 21999, Republic of Korea.
Jung Y; Department of Microbiology, College of Medicine, Gachon University, Incheon, 21999, Korea.
Kim YH; Gachon Pain Center and Department of Physiology, College of Medicine, Gachon University, Incheon, 21999, Republic of Korea. .
Lee HY; Division of Science Education, Kangwon National University, 24341, Chuncheon, Republic of Korea. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2023 Nov 10; Vol. 21 (1), pp. 323. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Video-Audio Media; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aspirin*/pharmacology
Aspirin*/metabolism
Stem Cells*
Pregnancy ; Female ; Animals ; Mice ; Humans ; Endometrium/metabolism ; Signal Transduction ; Cell Differentiation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Establishment of a forward primers-superposed amplification analysis for accurate aspirin pharmacogenomic measurement.
Autorzy:
Li CY; Institute of Biomedical Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, 250353, China.
Yang P; Institute of Biomedical Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, 250353, China.
Zheng J; Institute of Biomedical Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, 250353, China.
Zhang J; Institute of Biomedical Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, 250353, China.
Liu YQ; Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, China.
Liu XQ; Institute of Biomedical Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, 250353, China.
Hu Y; Institute of Biomedical Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, 250353, China. .
Lan WJ; Institute of Biomedical Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, 250353, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 09; Vol. 14 (1), pp. 880. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Pharmacogenetics*
Aspirin*
Alleles ; Genotype ; Biological Assay
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of an acute aspirin challenge on intestinal permeability in healthy adults with and without prophylactic probiotic consumption: a double-blind, placebo-controlled, randomized trial.
Autorzy:
Judkins TC; Food Science and Human Nutrition Department, University of Florida, 572 Newell Dr, Gainesville, FL, 32611, USA.
Solch-Ottaiano RJ; Food Science and Human Nutrition Department, University of Florida, 572 Newell Dr, Gainesville, FL, 32611, USA.
Ceretto-Clark B; Food Science and Human Nutrition Department, University of Florida, 572 Newell Dr, Gainesville, FL, 32611, USA.
Nieves C Jr; Food Science and Human Nutrition Department, University of Florida, 572 Newell Dr, Gainesville, FL, 32611, USA.
Colee J; IFAS Statistical Consulting Unit, University of Florida, PO Box 110500, Gainesville, FL, 32611-0500, USA.
Wang Y; Food Science and Human Nutrition Department, University of Florida, 572 Newell Dr, Gainesville, FL, 32611, USA.; Citrus Research and Education Center, Institute of Food and Agricultural Sciences, University of Florida, Lake Alfred, FL, 33850, USA.
Tompkins TA; Lallemand Bio-Ingredients, 1620 Rue Prefontaine, Montreal, QC, H1N 2W8, Canada.
Caballero-Calero SE; Lallemand Health Solutions, 6100 Royalmount Avenue, Montreal, QC, H4P 2R2, Canada.
Langkamp-Henken B; Food Science and Human Nutrition Department, University of Florida, 572 Newell Dr, Gainesville, FL, 32611, USA. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Jan 02; Vol. 24 (1), pp. 4. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Aspirin*
Probiotics*/therapeutic use
Adult ; Humans ; Intestinal Barrier Function ; Anti-Inflammatory Agents, Non-Steroidal ; Sucrose/urine ; Double-Blind Method
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression.
Autorzy:
Wang Y; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Wang M; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Liu C; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Hao M; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Wang W; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Li Y; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Shi J; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Zhang X; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China.
Dang S; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xi'an, 710004, Shaanxi, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 04; Vol. 13 (1), pp. 21362. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Aspirin*/therapeutic use
Carcinoma, Hepatocellular*/chemically induced
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/chemically induced
Liver Neoplasms*/drug therapy
Animals ; Rats ; B7-H1 Antigen ; Diethylnitrosamine/toxicity ; Inflammation/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Xiaojianzhong decoction attenuates aspirin-induced gastric mucosal injury via the PI3K/AKT/mTOR/ULK1 and AMPK/ULK1 pathways.
Autorzy:
Chen T; College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, PR China.; Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine, Xianyang, PR China.
Bao S; College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, PR China.; Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine, Xianyang, PR China.
Chen J; College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, PR China.; Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine, Xianyang, PR China.
Zhang J; College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, PR China.; Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine, Xianyang, PR China.
Wei H; Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine, Xianyang, PR China.; Department of General Surgery, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, PR China.
Hu X; State Forestry and Grassland Administration Engineering Research Center of Fu tea, Xianyang, PR China.
Liang Y; State Forestry and Grassland Administration Engineering Research Center of Fu tea, Xianyang, PR China.
Li J; Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine, Xianyang, PR China.; Department of Infectious Disease, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, PR China.
Yan S; College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, PR China.; Key Laboratory of Gastrointestinal Diseases and Prescriptions in Shaanxi Province, Shaanxi University of Chinese Medicine, Xianyang, PR China.
Pokaż więcej
Źródło:
Pharmaceutical biology [Pharm Biol] 2023 Dec; Vol. 61 (1), pp. 1234-1248.
Typ publikacji:
Journal Article
MeSH Terms:
Aspirin*/toxicity
Phosphatidylinositol 3-Kinases*
Stomach Diseases*/chemically induced
Stomach Diseases*/drug therapy
Drugs, Chinese Herbal*/pharmacology
Animals ; Mice ; AMP-Activated Protein Kinases ; Gastric Mucosa/drug effects ; Gastric Mucosa/pathology ; Mice, Inbred C57BL ; Proto-Oncogene Proteins c-akt ; TOR Serine-Threonine Kinases ; Signal Transduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Utility of Nasal Challenges to Phenotype Asthma Patients.
Autorzy:
Bentabol-Ramos G; Pulmonology Unit, Hospital Regional Universitario de Malaga, 29010 Malaga, Spain.
Saenz de Santa Maria-Garcia R; Allergy Unit, Hospital Regional Universitario de Malaga, 29010 Malaga, Spain.
Vidal-Diaz M; Pulmonology Unit, Hospital Regional Universitario de Malaga, 29010 Malaga, Spain.
Eguiluz-Gracia I; Allergy Unit, Hospital Regional Universitario de Malaga, 29010 Malaga, Spain.; Allergy Research Group, Instituto de Investigacion Biomedica de Malaga (IBIMA) and RICORS 'Enfermedades Inflamatorias', 29010 Malaga, Spain.
Testera-Montes A; Allergy Unit, Hospital Regional Universitario de Malaga, 29010 Malaga, Spain.; Allergy Research Group, Instituto de Investigacion Biomedica de Malaga (IBIMA) and RICORS 'Enfermedades Inflamatorias', 29010 Malaga, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Apr 27; Vol. 23 (9). Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Asthma*/chemically induced
Asthma*/diagnosis
Asthma*/therapy
Asthma, Aspirin-Induced*/diagnosis
Allergens ; Aspirin/therapeutic use ; Humans ; Phenotype
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.
Autorzy:
D'Souza GE; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Nwagu U; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Barton B; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Unsal AA; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Rabinowitz MR; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Rosen MR; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Nyquist GG; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Cohn J; Division of Pulmonary, Allergy and Critical Care Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Most J; Department of Pulmonary and Respiratory Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Toskala EM; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2022 Mar; Vol. 12 (3), pp. 306-309. Date of Electronic Publication: 2021 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma, Aspirin-Induced*/therapy
Biological Products*/adverse effects
Nasal Polyps*/therapy
Rhinitis*/therapy
Sinusitis*/chemically induced
Sinusitis*/therapy
Aspirin/adverse effects ; Chronic Disease ; Desensitization, Immunologic ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.
Autorzy:
Patel PP; Department of Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts, USA.
Cui J; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Division of Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Cahill KN; Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Laidlaw TM; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Feb; Vol. 52 (2), pp. 348-351. Date of Electronic Publication: 2021 Dec 01.
Typ publikacji:
Letter
MeSH Terms:
Asthma, Aspirin-Induced*/diagnosis
Anti-Inflammatory Agents, Non-Steroidal ; Aspirin/adverse effects ; Humans ; Patient Reported Outcome Measures
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 54679

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies